Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel.

Carl D RegilloLisa M NijmDiana L ShechtmanPeter K KaiserPaul M KarpeckiEdwin H RyanMichael S IpElizabeth YeuTerry KimMohammad R RafieetaryEric D Donnenfeld

Published in: Clinical ophthalmology (Auckland, N.Z.) (2024)

Newly approved treatments for patients with geographic atrophy are changing the treatment paradigm, highlighting the need for eye care providers (ECPs) to have a set of recommendations on how to best manage GA patients. Here, we outline how to identify various stages of age-related macular degeneration including geographic atrophy (GA) by examining optimal management scenarios implicating various ECPs and reviewing treatment considerations for patients with GA. Early identification of GA will lead to optimal patient outcomes, while a standardized management scenario will reduce clinical burden among ECPs treating patients with GA.

Keyphrases

pet ct
age related macular degeneration
end stage renal disease
newly diagnosed
chronic kidney disease
climate change
clinical practice
risk factors
patient reported outcomes
chronic pain
pain management
bioinformatics analysis
health insurance
replacement therapy